Looking for a career in health economics and real-world evidence (RWE)? Check out the latest job openings in the pharmaceutical industry. There are many new opportunities available for RWE analysts, real-world evidence scientists, RWE managers, and real-world evidence market access managers in both pharmaceutical and life science consulting companies.
Kirkland, Canada. Directeur(trice) associé(e), Économie de la santé et étude des résultats thérapeutiques Les principales fonctions du Directeur(trice) associé(e), Économie de la santé et étude des résultats thérapeutiques: Être responsable du positionnement stratégique des soumissions d’Évaluation des Technologies de la Santé (ETS) ; définir la stratégie de soumission et assurer l’alignement et l’accord au sein de l’organisation. Diriger la planification … Read more
Toronto, Canada. The Role In this role, you will support the local generation and adaptation of data, evidence and key HEOR deliverables for Moderna products supporting pricing and reimbursement, vaccine recommendations, tender and contracting and institutional customer engagement in Canada. This role leads local HEOR evidence generation and adaptation activities in Canada and provides strategic oversight of external research partners … Read more
Hyderabad, India. Job title: Manager – HEVA (Evidence Synthesis) Hiring Manager: Head/Group Lead/Team Lead Location: Hyderabad Travel expected: Required as per business need Job type: Permanent and Full time About the job Our Team: Sanofi Business Operations (SBO) is an internal Sanofi resource organization based in India and is setup to centralize processes and activities to support Specialty Care, Vaccines, … Read more
Ann Arbor, MI, US. Professor Kowalski is currently seeking candidates for a Research Area Specialist Intermediate position in the LSA Department of Economics. A strong, vibrant community of scholars focused on frontier economics scholarship and success for our students, faculty, staff, and alumni at every level. Successful candidates will collaborate closely with a research team on projects in the fields … Read more
Barcelona, Spain. Location: Barcelona – Spain (3 days working from the office and 2 days working from home) This is what you will do: The Associate Director, Global Health Economics & Outcomes Research (GHEOR) Analytics, develops and implements HEOR Analytics strategy, including conceptualizing real-world evidence studies, identification of data sources, study conduct and execution of publication plan. The incumbent will … Read more
West Point, PA, US / London, UK / Zurich, Switzerland. We have an exciting opportunity for a new Associate Principal Scientist to join our Oncology health economic modeling team in the Health Economic and Decision Sciences group. The preferred location for this role is West Point, PA; although alternate locations may be considered, including Rahway, NJ; Boston, MA; the UK, … Read more
Berlin, Germany. To strengthen our Pricing & Access Strategy and Value Strategy & RWE departments, we are looking for a Working Student (m/f/d) to join our Berlin office as soon as possible. Your mission Collaboration on interdisciplinary projects in the field of strategic consulting for leading pharmaceutical companies on topics related to market access for innovative drugs Support in the … Read more
Indianapolis, IN, US. At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen … Read more
Gif-sur-Yvertte, France. As a senior RWE statistician, you join an international and committed team, in charge of methodological and statistical approaches serving our real-world data studies and supporting related development plans. You drive the RWD studies you are assigned, ensuring state-of-the-art methodologies and deliverables, in compliance with regulatory guidelines as well as all Servier policies and procedures. Main responsibilities: Collaborates … Read more
Cambridge, MA, US. The Director, US Health Economics and Outcomes Research (HEOR) & Real World Evidence (RWE) is responsible for identifying real-world and economic evidence needs and developing the real-world, clinical, humanistic, and economic evidence generation plans in collaboration with internal business partners to support the value of our products for US healthcare providers, population-health decision makers, and other external … Read more
Amersfoort, Netherlands. As a Market Access Manager, you will make a direct impact on access to innovative care, working closely with national and international stakeholders. You will be responsible for achieving timely and sustainable reimbursement for our products in the Netherlands, including successfully completing health technology assessments and price negotiations. You will develop and implement the market access strategy, generate … Read more
Asker, Norway. At Takeda, we are committed to improving patient outcomes by ensuring access to innovative therapies. We are looking for a Market Access Manager to shape and deliver market access strategies across our portfolio in Norway. This is a high-impact, individual contributor role where you will lead national access strategy end-to-end, working cross-functionally and influencing key internal and external … Read more
Porto Salvo, Portugal. As a Market Access Trainee, you’ll join our team in Porto Salvo and gain hands-on experience in how innovative medicines reach patients. You’ll support work across pricing, reimbursement and health economics, while learning how we demonstrate the value of our therapies within the Portuguese healthcare system. Market Access brings together different areas of the business, so you’ll … Read more
Tokyo, Japan. HEOR director is a leadership member of Evidence and Observational Research (EOR) and leading HEOR team as a head of HEOR. Accountabilities: Establish HEOR organization and ensure the sufficient HEOR study management capabilities and capacity of the team members; Hold the ownership of the delivery of HEOR studies/projects, and accountable for the feasibility, progress, financial expense and the … Read more
Foster City, CA, US. The Epidemiology and Real-World Evidence (EpiRWE) function at Gilead is part of the Clinical Data Sciences (CDS) group within the Clinical Development organization and aims to unlock the power of Real-World Data (RWD) to help transform innovations to life-changing medicines for patients. The Senior Director, EpiRWE Oncology Franchise Lead in Early Development reports to the Executive … Read more
Real-World Evidence in Health Economics
Real-World Evidence in Health Economics
Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.
What is Real-World Evidence?
Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.
RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.
Importance of Real-World Evidence in Health Economics
RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.
RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.
Differences between RWE and Randomized Controlled Trials (RCTs)
RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.
RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.
RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.
Methods of Collecting RWE
There are several methods of collecting RWE, including:
Electronic Health Records (EHRs) EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.
Claims Databases Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.
Registries Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.
Patient-Reported Outcomes (PROs) PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.
Surveys Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.
Advantages of Real-World Evidence
There are several advantages of using RWE in health economics research, including:
RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
RWE can be used to evaluate interventions in a variety of settings and patient populations.
RWE can provide information on the long-term effectiveness and safety of interventions.
RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.
Challenges and Limitations of Real-World Evidence
There are several challenges and limitations to using RWE in health economics research, including:
RWE can be subject to bias and confounding, which can affect the validity of the results.
RWE can be difficult to collect and analyze, particularly when using multiple data sources.
RWE may not be as well-suited for evaluating rare diseases or interventions.
Applications of Real-World Evidence
RWE has several applications in health economics research, including:
Health Technology Assessment Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.
Comparative Effectiveness Research Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.
Post-Marketing Surveillance Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.
Future of Real-World Evidence in Health Economics
RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.
Looking for a career in health economics and real-world evidence (RWE)? Check out the latest job openings in the pharmaceutical industry. There are many new opportunities available for RWE analysts, real-world evidence scientists, RWE managers, and real-world evidence market access managers in both pharmaceutical and life science consulting companies.
We value your privacy. We use cookies to improve your experience on our website, personalise content and ads, and analyse our traffic. You can choose which cookies you allow, and you can withdraw your consent at any time. For more information, see our Cookie Policy.
